Polyclonal antibodies are the most preferred choice in routine laboratory tests, such as ELISA, microarray assays, western blotting, flow cytometry, and immunohistochemistry. Production of these does not require skilled professionals and large batches can be produced as per client requirements. A polyclonal antibody can recognize multiple antigens on one epitope and therefore can be utilized in the study of various diseases ranging from cancer to metabolic diseases. Denatured proteins are often detected with the use of polyclonal antibodies.
This report contains market size and forecasts of Mammalian Polyclonal IgG Antibody in global, including the following market information:
Global Mammalian Polyclonal IgG Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mammalian Polyclonal IgG Antibody Market Sales, 2017-2022, 2023-2028, (ml)
Global top five Mammalian Polyclonal IgG Antibody companies in 2021 (%)
The global Mammalian Polyclonal IgG Antibody market was valued at 989.9 million in 2021 and is projected to reach US$ 1312 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Mouse Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mammalian Polyclonal IgG Antibody include Polyclonal Antibody, Abcam PLC, Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, Merck KGaA, Cell Signalling Technologies, Inc and F. Hoffmann-La Roche Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mammalian Polyclonal IgG Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mammalian Polyclonal IgG Antibody Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (ml)
Global Mammalian Polyclonal IgG Antibody Market Segment Percentages, by Type, 2021 (%)
Mouse
Rabbit
Global Mammalian Polyclonal IgG Antibody Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (ml)
Global Mammalian Polyclonal IgG Antibody Market Segment Percentages, by Application, 2021 (%)
Cardiac Polyclonal IgG Antibody
Metabolic Polyclonal IgG Antibody
Global Mammalian Polyclonal IgG Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (ml)
Global Mammalian Polyclonal IgG Antibody Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mammalian Polyclonal IgG Antibody revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mammalian Polyclonal IgG Antibody revenues share in global market, 2021 (%)
Key companies Mammalian Polyclonal IgG Antibody sales in global market, 2017-2022 (Estimated), (ml)
Key companies Mammalian Polyclonal IgG Antibody sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Polyclonal Antibody
Abcam PLC
Bio-Rad Laboratories, Inc
Thermo Fisher Scientific
Merck KGaA
Cell Signalling Technologies, Inc
F. Hoffmann-La Roche Ltd.